• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年新冠病毒病(COVID-19)与季节性流感住院患者的比较流行病学和临床结局

Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023.

作者信息

Vlase Constantin-Marinel, Stuparu Cretu Mariana, Vasile Mihaela-Camelia, Popovici George-Cosmin, Arbune Manuela

机构信息

Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University Galati, 800008 Galati, Romania.

Military Hospital "Dr. Aristide Serfioti" Galați, 800008 Galati, Romania.

出版信息

Infect Dis Rep. 2024 Aug 23;16(5):783-793. doi: 10.3390/idr16050060.

DOI:10.3390/idr16050060
PMID:39311201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11417947/
Abstract

COVID-19 and influenza are highly contagious respiratory viral diseases and priority global public health concerns. We conducted a retrospective observational study of COVID-19 and/or influenza hospitalized cases, during 2023. We identified 170 influenza cases, 150 COVID-19 cases and 3 co-infections. Overall, 29.10% of patients had at least one COVID-19 vaccine dose and 4.6% received the seasonal Flu vaccine. The demographic data found older patients in the COVID-19 group and a higher index of the comorbidities, mainly due to chronic heart diseases, hypertension, and diabetes. Fever, chills, and rhinorrhea were more frequently related to influenza, while cough was prevalent in COVID-19. Antibiotics were more used in influenza than COVID-19, either pre-hospital or in-hospital. The mortality rate within the first 30 days from the onset of the respiratory infection was higher in influenza compared to COVID-19. We concluded that the COVID-19 clinical picture in hospitalized patients is changing to influenza-like symptoms. The evolution is variable, related to chronic comorbidities, but influenza had more frequent severe forms. All through 2023, due to poor vaccination rates, COVID-19 and influenza have continued to cause numerous hospitalizations, and a new strategy for efficient vaccinations is required.

摘要

新冠病毒病(COVID-19)和流感是具有高度传染性的呼吸道病毒性疾病,也是全球重点关注的公共卫生问题。我们对2023年期间因COVID-19和/或流感住院的病例进行了一项回顾性观察研究。我们确定了170例流感病例、150例COVID-19病例和3例合并感染病例。总体而言,29.10%的患者至少接种过一剂COVID-19疫苗,4.6%的患者接种了季节性流感疫苗。人口统计学数据显示,COVID-19组患者年龄较大,合并症指数较高,主要原因是慢性心脏病、高血压和糖尿病。发热、寒战和流鼻涕与流感的相关性更强,而咳嗽在COVID-19中更为常见。无论是院前还是院内,流感患者使用抗生素的频率都高于COVID-19患者。呼吸道感染发病后30天内,流感患者的死亡率高于COVID-19患者。我们得出结论,住院患者的COVID-19临床表现正在转变为类似流感的症状。其病情发展具有可变性,与慢性合并症有关,但流感的严重形式更为常见。在整个2023年,由于疫苗接种率低,COVID-19和流感继续导致大量住院病例,因此需要一种有效的疫苗接种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec0/11417947/426a47d5097e/idr-16-00060-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec0/11417947/d6bfb56ca49b/idr-16-00060-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec0/11417947/426a47d5097e/idr-16-00060-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec0/11417947/d6bfb56ca49b/idr-16-00060-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec0/11417947/426a47d5097e/idr-16-00060-g0A2.jpg

相似文献

1
Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023.2023年新冠病毒病(COVID-19)与季节性流感住院患者的比较流行病学和临床结局
Infect Dis Rep. 2024 Aug 23;16(5):783-793. doi: 10.3390/idr16050060.
2
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
3
[Technical guidelines for seasonal influenza vaccination in China (2023-2024)].《中国季节性流感疫苗接种技术指南(2023—2024年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10;44(10):1507-1530. doi: 10.3760/cma.j.cn112338-20230908-00139.
4
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
5
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
6
[Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain].[西班牙大加那利岛流感疫苗接种对新冠病毒病患者临床病程及两种病毒合并感染影响的流行病学研究]
Rev Esp Quimioter. 2023 Apr;36(2):180-186. doi: 10.37201/req/102.2022. Epub 2023 Jan 27.
7
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
8
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.德国因流感或 COVID-19 住院患者的临床结局和特征。
Int J Infect Dis. 2021 Feb;103:316-322. doi: 10.1016/j.ijid.2020.11.204. Epub 2020 Dec 31.
9
Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach.在疫苗接种的情况下减轻季节性流感和 COVID-19 大流行的共同传播:一种数学建模方法。
Front Public Health. 2023 Jan 4;10:1086849. doi: 10.3389/fpubh.2022.1086849. eCollection 2022.
10
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.

引用本文的文献

1
Dynamics of Clinical, Radiological, and Biological Expression in Hospitalised COVID-19 Patients and Post-Infectious Mortality: Comparison Between 2024 and 2020.住院COVID-19患者的临床、放射学和生物学表现动态及感染后死亡率:2024年与2020年的比较
Viruses. 2025 Apr 27;17(5):630. doi: 10.3390/v17050630.

本文引用的文献

1
The Detection of Influenza Virus Before and During the COVID-19 Pandemic in Cameroon.喀麦隆在新冠大流行前后对流感病毒的检测。
Influenza Other Respir Viruses. 2024 May;18(5):e13313. doi: 10.1111/irv.13313.
2
COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.新冠疫情和流感在罗马尼亚的疫苗接种情况,大流行后医护人员和普通人群的医疗保健经验教训。
PLoS One. 2024 Mar 7;19(3):e0299568. doi: 10.1371/journal.pone.0299568. eCollection 2024.
3
Post-viral sequelae of COVID-19 and influenza.新冠病毒病和流感的病毒感染后后遗症
Lancet Infect Dis. 2024 Mar;24(3):218-219. doi: 10.1016/S1473-3099(23)00762-4. Epub 2023 Dec 14.
4
Newer emerging SARS-COV2 variant: Omicron EG.5.新出现的新冠病毒变异株:奥密克戎EG.5
Ann Med Surg (Lond). 2023 Oct 4;85(12):5845-5846. doi: 10.1097/MS9.0000000000001386. eCollection 2023 Dec.
5
Changes in symptoms and characteristics of COVID-19 patients across different variants: two years study using neural network analysis.不同变异株 COVID-19 患者症状和特征的变化:使用神经网络分析的两年研究。
BMC Infect Dis. 2023 Nov 28;23(1):838. doi: 10.1186/s12879-023-08813-9.
6
Shifting Patterns of Influenza Circulation during the COVID-19 Pandemic, Senegal.新冠大流行期间塞内加尔流感传播模式的变化。
Emerg Infect Dis. 2023 Sep;29(9):1808-1817. doi: 10.3201/eid2909.230307.
7
The Changing Symptom Profile of COVID-19 During the Pandemic-Results From the German Mandatory Notification System.大流行期间COVID-19症状特征的变化——来自德国强制报告系统的结果
Dtsch Arztebl Int. 2023 Jun 16;120(24):420-421. doi: 10.3238/arztebl.m2023.0018.
8
Antibiotic Prescription in Patients With Coronavirus Disease 2019: Analysis of National Health Insurance System Data in the Republic of Korea.《2019 年冠状病毒病患者的抗生素处方:对大韩民国国家健康保险制度数据的分析》。
J Korean Med Sci. 2023 Jun 26;38(25):e189. doi: 10.3346/jkms.2023.38.e189.
9
A systematic review of the clinical characteristics of influenza-COVID-19 co-infection.一项关于流感-COVID-19 合并感染的临床特征的系统回顾。
Clin Exp Med. 2023 Nov;23(7):3265-3275. doi: 10.1007/s10238-023-01116-y. Epub 2023 Jun 16.
10
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.2022/23 年度流感疫苗有效性中期报告:2022 年 10 月至 2023 年 1 月期间的六项欧洲研究。
Euro Surveill. 2023 May;28(21). doi: 10.2807/1560-7917.ES.2023.28.21.2300116.